Description

5-((6,8-Dichloro-4-Oxo(4H-Chromen-3-Yl))Methylene)-3-Ethyl-2-Thioxo-1,3-Thiazolidin-4-One is a high-purity, advanced pharmaceutical intermediate designed for the synthesis of novel active pharmaceutical ingredients (APIs). This compound matters because it serves as a critical building block in medicinal chemistry, enabling the development of new therapeutic agents with potential activity in areas such as oncology and inflammation. It is primarily needed by R&D chemists, process development scientists, and manufacturers in the pharmaceutical, biotechnology, and fine chemical industries.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel chromene and thiazolidinone-based drug candidates.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization programs for new molecular entities.
• API Development: Serves as a core scaffold for developing potential therapeutic agents targeting specific enzymes or receptors.
• Biochemical Research: Employed as a tool compound in biochemical assays to study biological pathways and mechanisms of action.
• Fine Chemical Synthesis: Utilized in custom synthesis and contract manufacturing for specialized, high-value chemical products.

Basic Information

Product Name	5-((6,8-Dichloro-4-Oxo(4H-Chromen-3-Yl))Methylene)-3-Ethyl-2-Thioxo-1,3-Thiazolidin-4-One
CAS No.	1367579-02-9
Molecular Formula	C₁₅H₉Cl₂NO₃S₂
Molecular Weight	386.27 g/mol
Synonyms	5-[(6,8-Dichloro-4-oxo-4H-chromen-3-yl)methylene]-3-ethyl-2-thioxo-1,3-thiazolidin-4-one; 3-Ethyl-5-((6,8-dichloro-4-oxo-4H-chromen-3-yl)methylene)-2-thioxothiazolidin-4-one; Chromene-thiazolidinone derivative; 1367579-02-9; 5-((6,8-Dichloro-4-oxo(4H-chromen-3-yl))methylene)-3-ethyl-2-thioxo-1,3-thiazolidin-4-one
EINECS	Contact for details

Quality Control

Our 5-((6,8-Dichloro-4-Oxo(4H-Chromen-3-Yl))Methylene)-3-Ethyl-2-Thioxo-1,3-Thiazolidin-4-One is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing all specifications is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). The compound may be light-sensitive; prolonged exposure to light should be avoided. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	Yellow to orange solid powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.